Not independent
Tenure on this board
10.4 yrs
7 nominees · 5 ballot items.
Elect seven directors; ratify Cherry Bekaert LLP as independent auditors; approve an amendment to the 2025 Equity Incentive Plan to add 5,250,000 shares; approve a reverse stock split (ratio between 1-for-10 and 1-for-100) with ratio and timing set by the Board; and approve adjournment(s) to permit further solicitation of proxies if necessary.
Elect seven directors (Christer Rosén; Marshall Hayward, Ph.D.; Alison D. Silva; Nicholas H. Hemmerly; Andrew J. Cutler, M.D.; Tomas J. Philipson; Holger Weis) each to serve until the 2027 annual meeting and until their successors are elected and qualified.
Ratify the selection of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Approve an amendment to the 2025 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 5,250,000 shares of Common Stock.
This proposal asks shareholders to approve a board‑and‑committee‑approved amendment to the Company’s 2025 Equity Incentive Plan to add 5,250,000 shares to the plan reserve. Management is seeking shareholder approval to ensure compliance with Nasdaq listing rules and standard governance/tax requirements for incentive stock options, and to provide the Compensation Committee with additional equity to grant both service‑ and performance‑based awards to employees, executives, consultants and non‑employee directors. The filing states the Board believes the currently available shares are insufficient for anticipated grant needs and that the additional shares would support long‑term employee retention and alignment of management and stockholder interests; management estimates the increase would supply an adequate run‑rate of awards for roughly two additional years. The amendment retains standard plan features: administration by the Compensation Committee, authority to grant a variety of award types (ISOs, non‑qualified options, RSUs, SARs, restricted stock, performance awards), anti‑dilution adjustments, change‑in‑control provisions, and limits on awards to non‑employee directors. The Company discloses existing outstanding awards and recent grants, which shows that meaningful option pools have already been used, so the amendment will dilute existing holders to some degree and increase share overhang. Vote mechanics require a majority of votes cast for approval; the Board unanimously recommends “FOR.” The principal risk to shareholders is dilution and potential overhang; the potential benefits are improved recruiting/retention and stronger pay‑for‑performance alignment. Analysts should weigh the increase relative to current outstanding options and planned hiring/grant schedules and model the potential dilutive impact against the expected retention and performance benefits.
Approve an amendment to the Certificate of Incorporation to effect a reverse stock split of the common stock at a ratio not less than 1-for-10 and not more than 1-for-100, with the exact ratio and timing to be determined by the Board.
The proposal seeks shareholder authorization to amend the Certificate of Incorporation to permit the Board to implement a reverse stock split at a flexible ratio between 1-for-10 and 1-for-100, if the Board determines doing so is in the Company’s best interest. Management’s stated objective is to raise the per‑share market price to regain compliance with Nasdaq’s minimum $1.00 bid price rule and potentially the market‑value listing threshold; the Company disclosed Nasdaq notices of noncompliance for minimum bid price and market value of listed securities and cited the August 25, 2026 compliance deadline. The Board argues a higher per‑share price could expand the institutional investor universe, reduce brokerages’ internal restrictions on low‑priced stocks, and improve perceived liquidity and marketability. The proposal delegates the exact ratio and timing to the Board, giving the company discretion to choose the option that best balances listing compliance and market impact. Material downsides described in the filing include potential reduced liquidity from fewer outstanding shares, odd‑lot complications, and the risk that the market price may not sustain a post‑split increase (and total market capitalization could decline). The filing explains mechanics for rounding fractional shares and adjusting options, warrants and RSUs, and reserves the Board’s right to abandon the split even if authorized. The vote requires a majority of votes cast; the Board unanimously recommends “FOR.” Analysts should assess the company’s likelihood of curing Nasdaq deficiencies without a split, the appropriate split ratio tradeoffs (e.g., 1:10 vs. 1:100), and the potential dilutive/economic effects on outstanding derivatives and shareholder liquidity.
Approve adjournment(s) of the Annual Meeting, if necessary, to permit further solicitation of proxies in the event of insufficient votes to approve a proposal or to establish a quorum.
This is a routine management proposal seeking shareholder approval to allow the Board or meeting chair to adjourn the Annual Meeting to permit additional time to solicit proxies if there are insufficient votes or no quorum. Management requests this authority as a procedural safeguard to allow the company to continue outreach to shareholders and attempt to obtain the votes necessary to approve substantive proposals, avoiding an immediate failure of any proposal solely due to timing or insufficient solicitation. If approved, adjournment would not itself change substantive rights or outcomes, but it could extend the timeline for final decisions and permit further outreach that might affect the eventual vote tally. The proposal requires a majority of shares present in person or by proxy; the Board unanimously recommends “FOR.” Investors should view this as an administrative governance tool rather than a substantive transaction — its primary consequence is potential delay of final voting results and additional solicitation costs.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VESTOR CAPITAL, LLC | 2.7% | 970,985 | $365 |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.0% | 359,911 | $135K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.5% | 174,856 | $66K |
| 4 | Yorkville Advisors Global, LP | 0.4% | 129,000 | $49K |
| 5 | CITADEL ADVISORS LLC | 0.3% | 101,661 | $38K |
| 6 | VANGUARD FIDUCIARY TRUST CO | 0.2% | 87,789 | $33K |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.1% | 36,840 | $14K |
| 8 | NORTHERN TRUST CORP | 0.1% | 25,346 | $10K |
| 9 | Virtu Financial LLC | 0.0% | 13,575 | $5 |
| 10 | UBS Group AG | 0.0% | 3,928 | $1K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.